LEFTWICH SCOTT purchased 2212.4% of their position (125K shares) of CALIDI BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $250.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/25/2025ACC: 0001641172-25-025446
Director
Since Sep 2023
+250K
Net shares
Net buyer
$250.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
250K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+125K
Price / share
$2.00
Trade value
$250K
% of position
2212.4%
8/21/2025
5.65K→130.65K
Total
Net shares
+125K
Net value
$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | P · Purchase | +125K | $2.00 | $250K | 2212.4% | 5.65K | 130.65K |
| Total | +125K | $250K | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common stock
125K shares
Shares
+125K
Strike price
2.00
Held after
125K
Exercisable
—
8/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common stock125K shares | 8/21/2025 | P · Purchase | +125K | 2.00 | — | 125K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned14.67K
Common Stock
IndirectShares owned1.31K
Total
15.98K indirect15.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.67K | Indirect |
| Common Stock | 1.31K | Indirect |
| Total | 15.98K | 15.98K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported